Correlation Between Rigel Pharmaceuticals and Verastem
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Verastem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Verastem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Verastem, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Verastem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Verastem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Verastem.
Diversification Opportunities for Rigel Pharmaceuticals and Verastem
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Rigel and Verastem is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Verastem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verastem and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Verastem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verastem has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Verastem go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Verastem
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 0.71 times more return on investment than Verastem. However, Rigel Pharmaceuticals is 1.41 times less risky than Verastem. It trades about 0.07 of its potential returns per unit of risk. Verastem is currently generating about 0.03 per unit of risk. If you would invest 873.00 in Rigel Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 1,915 from holding Rigel Pharmaceuticals or generate 219.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Verastem
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Verastem |
Rigel Pharmaceuticals and Verastem Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Verastem
The main advantage of trading using opposite Rigel Pharmaceuticals and Verastem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Verastem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will offset losses from the drop in Verastem's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |